Great West Life Assurance CO Arcutis Biotherapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 8,233 shares of ARQT stock, worth $88,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,233
Previous 8,233
-0.0%
Holding current value
$88,669
Previous $76,000
1.32%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$126 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$118 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$115 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$94.6 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$92.9 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $648M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...